Durability of ChAdOx1 nCoV-19 (AZD1222) vaccine and hybrid humoral immunity against variants including omicron BA.1 and BA.4 6 months after vaccination (COV005): a post-hoc analysis of a randomised, phase 1b-2a trial
ChAdOx1 nCoV-19 (AZD1222) 疫苗接种后 6 个月针对包括 omicron BA.1 和 BA.4 在内的变异株的持久性及混合体液免疫（COV005）：一项随机 1b-2a 期试验的事后分析
期刊:Lancet Infectious Diseases
影响因子:31
doi:10.1016/S1473-3099(22)00596-5
Madhi, Shabir A; Kwatra, Gaurav; Richardson, Simone I; Koen, Anthonet L; Baillie, Vicky; Cutland, Clare L; Fairlie, Lee; Padayachee, Sherman D; Dheda, Keertan; Barnabas, Shaun L; Bhorat, Qasim Ebrahim; Briner, Carmen; Ahmed, Khatija; Aley, Parvinder K; Bhikha, Sutika; Bhorat, A E; Esmail, Aliasgar; Horne, Elizea; Kaldine, Haajira; Mukendi, Christian K; Madzorera, Vimbai Sharon; Manamela, Nelia P; Masilela, Mduduzi; Hermanus, S Tandile; Motlou, Thopisang; Mzindle, Nonkululeko; Oelofse, Suzette; Patel, Faeezah; Rhead, Sarah; Rossouw, Lindie; Taoushanis, Carol; van Eck, Samuel; Lambe, Teresa; Gilbert, Sarah C; Pollard, Andrew J; Moore, Penny L; Izu, Alane
